Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate NeuroPace, Inc. before investing.

In this article, we go over a few key elements for understanding NeuroPace, Inc.’s stock price such as:

• NeuroPace, Inc.’s current stock price and volume
• Why NeuroPace, Inc.’s stock price changed recently
• Upgrades and downgrades for NPCE from analysts
• NPCE’s stock price momentum as measured by its relative strength

About NeuroPace, Inc. (NPCE)

Before we jump into NeuroPace, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Want to learn more about NeuroPace, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about NeuroPace, Inc..

NeuroPace, Inc.’s Stock Price as of Market Close

As of May 15, 2025, 12:47 PM, CST, NeuroPace, Inc.’s stock price was $17.655.

NeuroPace, Inc. is up 13.17% from its previous closing price of $15.600.

During the last market session, NeuroPace, Inc.’s stock traded between $15.260 and $17.730. Currently, there are approximately 31.48 million shares outstanding for NeuroPace, Inc..

NeuroPace, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

NeuroPace, Inc. Stock Price History

NeuroPace, Inc.’s (NPCE) price is currently up 51.03% so far this month.

During the month of May, NeuroPace, Inc.’s stock price has reached a high of $17.730 and a low of $11.190.

Over the last year, NeuroPace, Inc. has hit prices as high as $16.357 and as low as $5.450. Year to date, NeuroPace, Inc.’s stock is up 57.77%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused NeuroPace, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of May 14, 2025,, no analysts have changed their rating of NeuroPace, Inc.’s stock over the last month.

Additionally, you'll want to evaluate NeuroPace, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on NeuroPace, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

NeuroPace, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about NeuroPace, Inc. (NPCE) by visiting AAII Stock Evaluator.

Relative Price Strength of NeuroPace, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 14, 2025, NeuroPace, Inc. has a weighted four-quarter relative price strength of 20.72%, which translates to a Momentum Score of 94 and is considered to be Very Strong.

Want to learn more about how NeuroPace, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

NeuroPace, Inc. Stock Price: Bottom Line

As of May 15, 2025, NeuroPace, Inc.’s stock price is $17.655, which is up 13.17% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like NeuroPace, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.